BackAscelia Pharma AB (publ) Overview

Ascelia Pharma AB (publ) Current Assets

Ascelia Pharma AB (publ)'s current assets is $33M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$32.90M
↓ 57.92% YoYΔ $-45.28M vs prior year quarter

Peer trimmed avg / median

Loading

Ascelia Pharma AB (publ) Current Assets History

Loading

Ascelia Pharma AB (publ) vs. peers: Current Assets Comparison

Loading

Ascelia Pharma AB (publ) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ascelia Pharma AB (publ) (ACE.ST) FAQ

As of the most recent data (September 2026), ACE.ST shows a current assets of $33M. That compares with $78M in the prior-year period — down 57.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACE.ST's current assets is now $33M (was $78M) — a 57.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ascelia Pharma AB (publ) is outperforming or lagging.

Tracking ACE.ST's current assets over time shows whether Ascelia Pharma AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $33M That compares with $78M in the prior-year period — down 57.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Ascelia Pharma AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $33M) with ownership activity and broader fundamentals.

Ascelia Pharma AB (publ)'s current assets is $33M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers